Merck & Co Inc (MRK)
101.88
-0.44
(-0.43%)
USD |
NYSE |
Nov 01, 16:00
101.94
+0.06
(+0.06%)
After-Hours: 20:00
Merck Total Liabilities (Quarterly): 68.98B for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 68.98B |
| March 31, 2024 | 65.42B |
| December 31, 2023 | 69.04B |
| September 30, 2023 | 65.43B |
| June 30, 2023 | 65.73B |
| March 31, 2023 | 60.89B |
| December 31, 2022 | 63.10B |
| September 30, 2022 | 62.56B |
| June 30, 2022 | 63.78B |
| March 31, 2022 | 65.72B |
| December 31, 2021 | 67.44B |
| September 30, 2021 | 57.63B |
| June 30, 2021 | 57.30B |
| March 31, 2021 | 63.81B |
| December 31, 2020 | 66.18B |
| September 30, 2020 | 60.53B |
| June 30, 2020 | 62.87B |
| March 31, 2020 | 58.61B |
| December 31, 2019 | 58.40B |
| September 30, 2019 | 56.41B |
| June 30, 2019 | 56.23B |
| March 31, 2019 | 54.68B |
| December 31, 2018 | 55.76B |
| September 30, 2018 | 52.47B |
| June 30, 2018 | 52.27B |
| Date | Value |
|---|---|
| March 31, 2018 | 52.14B |
| December 31, 2017 | 53.30B |
| September 30, 2017 | 53.18B |
| June 30, 2017 | 53.09B |
| March 31, 2017 | 56.47B |
| December 31, 2016 | 55.07B |
| September 30, 2016 | 54.38B |
| June 30, 2016 | 53.03B |
| March 31, 2016 | 54.85B |
| December 31, 2015 | 56.91B |
| September 30, 2015 | 55.55B |
| June 30, 2015 | 55.94B |
| March 31, 2015 | 60.43B |
| December 31, 2014 | 49.38B |
| September 30, 2014 | 56.45B |
| June 30, 2014 | 49.34B |
| March 31, 2014 | 55.90B |
| December 31, 2013 | 53.32B |
| September 30, 2013 | 56.41B |
| June 30, 2013 | 56.77B |
| March 31, 2013 | 50.59B |
| December 31, 2012 | 50.67B |
| September 30, 2012 | 48.09B |
| June 30, 2012 | 47.85B |
| March 31, 2012 | 48.20B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
57.30B
Minimum
Jun 2021
69.04B
Maximum
Dec 2023
63.34B
Average
63.78B
Median
Jun 2022
Total Liabilities (Quarterly) Benchmarks
| Amgen Inc | 83.36B |
| Johnson & Johnson | 108.13B |
| Eli Lilly and Co | 61.29B |
| Pfizer Inc | 128.22B |
| Moderna Inc | 3.968B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 112.63B |
| Shareholders Equity (Quarterly) | 43.58B |
| Debt to Equity Ratio | 0.8671 |
| Current Ratio | 1.466 |
| Net Debt Paydown Yield | 2.56% |